AANPCB PMHNP-C flashcards
AANPCB PMHNP-C · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- C-SSRS purpose
- A structured interview that grades suicidal ideation from passive wishes to active intent with plan, plus suicidal behavior, to stratify risk and guide safety planning.
- PHQ-9 severity cutoffs
- Scores of 5-9 indicate mild, 10-14 moderate, 15-19 moderately severe, and 20 or higher severe depression; item 9 screens for suicidal thoughts.
- CAM delirium criteria
- Requires acute onset with fluctuating course plus inattention, and either disorganized thinking or altered level of consciousness, to identify delirium.
- SIGECAPS mnemonic
- Screens the nine depressive symptom domains: Sleep, Interest, Guilt, Energy, Concentration, Appetite, Psychomotor changes, and Suicidal ideation, used to assess major depression.
- AUDIT-C positive thresholds
- A brief alcohol screen scored positive at 4 or more in men and 3 or more in women, indicating hazardous drinking that warrants further assessment.
- Standard drink definition
- Contains 14 grams of ethanol, equivalent to 12 ounces beer, 5 ounces wine, or 1.5 ounces distilled spirits, used to quantify alcohol intake.
- GAD-7 scoring
- Scores of 5-9 indicate mild, 10-14 moderate, and 15 or higher severe anxiety; a score of 10 or more often triggers treatment.
- Mental status exam domains
- Systematically covers appearance, behavior, speech, mood and affect, thought process and content, perception, cognition, insight, and judgment during assessment.
- Major depressive episode criteria
- Five or more of nine symptoms for at least two weeks, including depressed mood or anhedonia, causing clinically significant impairment or distress.
- Manic episode duration
- Elevated or irritable mood with increased energy lasting at least one week, or any duration if hospitalization is required, with three or more associated symptoms.
- Hypomania definition
- Distinctly elevated or irritable mood lasting at least four consecutive days without marked impairment, psychosis, or need for hospitalization, differentiating it from mania.
- Schizophrenia core criteria
- Two or more symptoms among delusions, hallucinations, disorganized speech, disorganized or catatonic behavior, and negative symptoms, with at least one from the first three.
- ADHD adult symptom threshold
- Requires at least five inattentive or hyperactive-impulsive symptoms, present before age 12, across two or more settings, with functional impairment.
- Generalized anxiety disorder criteria
- Excessive worry for six months or more that is hard to control, plus three of six symptoms such as restlessness, fatigue, concentration difficulty, irritability, tension, or sleep disturbance.
- PTSD symptom clusters
- Requires intrusion, avoidance, negative cognition or mood, and arousal or reactivity symptoms lasting more than one month after trauma exposure.
- Panic attack definition
- An abrupt surge of intense fear peaking within minutes with four or more of thirteen symptoms, such as palpitations, dyspnea, choking, or fear of dying.
- Bipolar I vs bipolar II
- Bipolar I requires at least one manic episode; bipolar II requires hypomania plus major depression without any full manic episode.
- SSRI titration timeline
- Start at a low dose, reassess after four to six weeks at an adequate dose, and allow four to eight weeks for full therapeutic response.
- Serotonin syndrome triad
- Mental status changes, autonomic hyperactivity, and neuromuscular abnormalities such as clonus and hyperreflexia; stop serotonergic drugs and give supportive care.
- Bupropion contraindications
- Avoid in seizure disorders, bulimia or anorexia nervosa, and abrupt alcohol or benzodiazepine withdrawal because it lowers the seizure threshold.
- Lithium therapeutic range
- Serum trough levels of 0.6 to 1.2 mEq/L are typical for maintenance; recheck levels five days after any dose change.
- Antipsychotic metabolic monitoring
- Obtain baseline weight, waist circumference, blood pressure, fasting glucose or A1c, and lipids, then repeat periodically to detect metabolic syndrome.
- Benzodiazepine Beers caution
- Older adults should generally avoid benzodiazepines due to increased risk of falls, fractures, cognitive impairment, and delirium.
- Opioid use disorder first line
- Buprenorphine or methadone maintenance is first-line pharmacotherapy; naltrexone is an alternative after detoxification and abstinence.
- Treatment response vs remission
- Response is at least a 50 percent reduction in symptom scale score; remission is near-absent symptoms, such as a PHQ-9 below 5.
- Inadequate antidepressant response
- After four to eight weeks at an adequate dose, confirm adherence and diagnosis before switching agents or augmenting therapy.
- QTc risk thresholds
- A QTc above 500 milliseconds or an increase over 60 milliseconds from baseline warrants stopping or changing the QT-prolonging medication.
- Clozapine ANC monitoring
- Absolute neutrophil count checks weekly for six months, then every two weeks for six months, then every four weeks thereafter.
- Lithium adverse effect monitoring
- Periodically check renal function, thyroid, and calcium; tremor, polyuria, and weight gain may signal adverse effects or toxicity.
- Antidepressant activation monitoring
- After starting an antidepressant, screen for emergent suicidality, agitation, or mania, especially in youth and young adults during early treatment.
- Relapse prevention duration
- Continue antidepressants for at least six to twelve months after remission, and longer for patients with recurrent or chronic episodes.
- Naranjo adverse reaction scale
- Estimates the probability that a symptom is drug-related; scores of 9 or higher are definite and 5 to 8 probable.